These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23958716)

  • 1. Effect of rituximab in MCNS: a role for IL-13 suppression?
    Kim JE; Park SJ; Ha TS; Shin JI
    Nat Rev Nephrol; 2013 Sep; 9(9):551. PubMed ID: 23958716
    [No Abstract]   [Full Text] [Related]  

  • 2. [Idiopathic nephrotic syndrome in children: from corticosteroids to rituximab].
    Deschênes G
    Arch Pediatr; 2011 Aug; 18(8):843-5. PubMed ID: 21719260
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beneficial effects of rituximab in the treatment of refractory nephrotic syndrome].
    Imai E
    Nihon Jinzo Gakkai Shi; 2012; 54(5):593-7. PubMed ID: 22991838
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for early relapse during maintenance therapy after a single infusion of rituximab in children with steroid-dependent nephrotic syndrome.
    Fujinaga S; Hirano D
    Pediatr Nephrol; 2014 Mar; 29(3):491-2. PubMed ID: 24240472
    [No Abstract]   [Full Text] [Related]  

  • 5. Repeated course of rituximab for treatment of nephrotic syndrome in patients with chronic GVHD.
    Mellon-Reppen S; Ratanatharathorn V; Cronin S; Uberti JP
    Bone Marrow Transplant; 2010 Dec; 45(12):1758-9. PubMed ID: 20383208
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab followed by mycophenolate mofetil in children with IgM nephropathy.
    Gu J; Xia Y; Mao J; Fu H; Liu A
    Indian Pediatr; 2012 Oct; 49(10):831-3. PubMed ID: 23144102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab in steroid-dependent nephrotic syndrome.
    El Koumi M
    Iran J Kidney Dis; 2013 Nov; 7(6):502-6. PubMed ID: 24241100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab therapy in nephrotic syndrome: implications for patients' management.
    Sinha A; Bagga A
    Nat Rev Nephrol; 2013 Mar; 9(3):154-69. PubMed ID: 23338210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab for childhood refractory nephrotic syndrome.
    Iijima K
    Pediatr Int; 2011 Oct; 53(5):617-621. PubMed ID: 21771179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab for refractory cases of childhood nephrotic syndrome.
    Kari JA; El-Morshedy SM; El-Desoky S; Alshaya HO; Rahim KA; Edrees BM
    Pediatr Nephrol; 2011 May; 26(5):733-7. PubMed ID: 21279725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotic syndrome and rituximab: facts and perspectives.
    Haffner D; Fischer DC
    Pediatr Nephrol; 2009 Aug; 24(8):1433-8. PubMed ID: 19495800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is rituximab effective in childhood nephrotic syndrome? Yes and no.
    Kemper MJ; Lehnhardt A; Zawischa A; Oh J
    Pediatr Nephrol; 2014 Aug; 29(8):1305-11. PubMed ID: 23820888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome?
    Smith GC
    Pediatr Nephrol; 2007 Jun; 22(6):893-8. PubMed ID: 17310362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapies: Is there a role for rituximab in nephrotic syndrome?
    Feehally J
    Nat Rev Nephrol; 2014 May; 10(5):245-7. PubMed ID: 24614409
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.
    Kemper MJ; Gellermann J; Habbig S; Krmar RT; Dittrich K; Jungraithmayr T; Pape L; Patzer L; Billing H; Weber L; Pohl M; Rosenthal K; Rosahl A; Mueller-Wiefel DE; Dötsch J
    Nephrol Dial Transplant; 2012 May; 27(5):1910-5. PubMed ID: 22076431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults.
    Takei T; Itabashi M; Moriyama T; Kojima C; Shiohira S; Shimizu A; Tsuruta Y; Ochi A; Amemiya N; Mochizuki T; Uchida K; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2013 May; 28(5):1225-32. PubMed ID: 23239834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for childhood-onset nephrotic syndrome.
    Hodson EM; Craig JC
    Lancet; 2014 Oct; 384(9950):1242-3. PubMed ID: 24965824
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab in steroid-resistant nephrotic syndrome in children: a (false) glimmer of hope?
    Pradhan M; Furth S
    J Am Soc Nephrol; 2012 Jun; 23(6):975-8. PubMed ID: 22581992
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful use of single-dose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndrome.
    Kurosu N; Sugiura H; Iwasaki C; Asamiya Y; Kojima C; Moriyama T; Itabashi M; Tsukada M; Takei T; Ogawa T; Yoshida T; Uchida K; Tsuchiya K; Nitta K
    Intern Med; 2009; 48(21):1901-4. PubMed ID: 19881243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab treatment for recurrence of nephrotic syndrome in a pediatric patient after renal transplantation for congenital nephrotic syndrome of Finnish type.
    Chaudhuri A; Kambham N; Sutherland S; Grimm P; Alexander S; Concepcion W; Sarwal M; Wong C
    Pediatr Transplant; 2012 Aug; 16(5):E183-7. PubMed ID: 21672106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.